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Trypanosoma cruzi species is categorized into six discrete typing units (TcI to TcVI) of which TcI is most abundantly noted in
the sylvatic transmission cycle and considered the major cause of human disease. In our study, the TcI strains Colombiana
(COL), SylvioX10/4 (SYL), and a cultured clone (TCC) exhibited different biological behavior in a murine model, ranging from
high parasitemia and symptomatic cardiomyopathy (SYL), mild parasitemia and high tissue tropism (COL), to no pathogenicity
(TCC). Proteomic profiling of the insect (epimastigote) and infective (trypomastigote) forms by two-dimensional gel electropho-
resis/matrix-assisted laser desorption ionization–time of flight mass spectrometry, followed by functional annotation of the dif-
ferential proteome data sets (>2-fold change, P< 0.05), showed that several proteins involved in (i) cytoskeletal assembly and
remodeling, essential for flagellar wave frequency and amplitude and forwardmotility of the parasite, and (ii) the parasite-spe-
cific antioxidant network were enhanced in COL and SYL (versus TCC) trypomastigotes. Western blotting confirmed the en-
hanced protein levels of cytosolic andmitochondrial tryparedoxin peroxidases and their substrate (tryparedoxin) and iron su-
peroxide dismutase in COL and SYL (versus TCC) trypomastigotes. Further, COL and SYL (but not TCC) were resistant to
exogenous treatment with stable oxidants (H2O2 and peroxynitrite [ONOO
]) and dampened the intracellular superoxide and
nitric oxide response in macrophages, and thus these isolates escaped frommacrophages. Our findings suggest that protein ex-
pression conducive to increase in motility and control of macrophage-derived free radicals provides survival and persistence
benefits to TcI isolates of T. cruzi.
Chagas disease, caused by the unicellular protozoan Trypano-soma cruzi, is ranked as the third most important parasitic
disease in terms of disability-adjusted life years (1, 2). T. cruzi is
naturally transmitted by Triatomine insects. In recent years, a sig-
nificant proportion of the infected population has emigrated from
rural areas, leading to the urbanization of Chagas disease in coun-
tries where the disease is endemic, as well as internationally (1).
Chagas disease is therefore an emergent global public health prob-
lem associated with congenital transmission (3, 4), blood transfu-
sions (5), and organ transplantations (6). Current estimates sug-
gest that70million people are at risk of infection (7, 8) and that
6 million individuals are infected with T. cruzi in Latin America
and Mexico. However, these estimates may not be accurate, since
they are not derived from detailed epidemiological studies. For
example, in Argentina, the Chagas Disease National Control Pro-
gram reported 13 provinces located in the Central-Northeast area
as endemic for Chagas disease in 2010 (9). Vectorial transmission
was reported to be absent in Jujuy, Entre Ríos, La Pampa, Neu-
quén, and Río Negro but active in provinces such as Formosa,
Chaco, Córdoba, Santiago del Estero, and others, with a Triatoma
infestans infestation index of 18.1% (national average, 10.2%) (9).
In the state of Salta that shares borders with Bolivia and Paraguay,
national data indicated a 7.5% seroprevalence (5.7% for blood
donors and 1.82% among young children); however, several re-
search groups reported up to 27% seropositivity fromfield surveys
in restricted geographical areas (10, 11). These observations may
mean the existence of heterogeneity in the epidemiologic situation
related to Chagas disease in regions where it is endemic.
Acute Chagas disease carries a mortality rate of5% (12), and
an asymptomatic or indeterminate stage is most commonly pre-
sented in those surviving the acute infection. However, several
decades later, infected individuals develop clinically symptomatic
cardiac (30%) or digestive (8 to 10%) forms of Chagas disease
(13). The chagasic megacolon is primarily presented in cases in
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Central Brazil and Chile but is largely nonexistent in those in
Venezuela and parts of Central America (14). The situation in
Argentina is not very clear; however, epidemiological data suggest
that genetic variations of both host and the parasite play an im-
portant role in determining the development of clinical disease in
infected individuals.
Trypanosoma (Schizotrypanum) cruzi belongs to the order Kin-
etoplastida, which comprises flagellar organisms with a kineto-
plast organelle located in the cell mitochondrion. T. cruzi is in-
cluded in the stercorarian section, together with the group of
trypanosomes whose infective stage develops in the vectors’ diges-
tive tract and contaminates the mammalian hosts through feces
(15). The subgenus Schizotrypanum has been adopted to identify
the intracellular replicative stage. At present, based upon molec-
ular and multilocus enzyme electrophoresis analyses, T. cruzi iso-
lates are classified into six discrete typing units (DTU) referred to
as TcI to TcVI (16). Of these, TcI has the widest distribution and is
the most common cause of disease in Colombia and Venezuela
(17), and in the northern region of South America and the United
States (4, 18). Although T. cruzi isolates belonging to other DTU
(e.g., TcII, TcV, and TcVI) have been identified in peripheral
blood of seropositive patients in Southern Cone countries of
South America (19), TcI isolates were mainly reported in heart
biopsy specimens from chronic chagasic patients in the Southern
Cone countries (20, 21). These findings suggested to us that pa-
tients could be carrying a mixed infection, with TcI associated
with the development of clinical cardiac disease. Other studies
have, however, failed to find a reliable association between cardio-
myopathy and TcI DTU (22).
In this study, we aimed to identify whether diversity at the
virulence level exists among the TcI isolates of T. cruzi, and we
investigated the potential molecular mechanism(s) responsible
for diversity in virulence and pathogenicity of the TcI isolates. We
examined the infectivity and virulence of three TcI strains chosen
based upon their diverse origin, which included the Colombiana
strain (COL) recovered froma chronically infected humanpatient
fromColombia (23); the Sylvio-X10 strain (SYL) isolated from an
acutely infected human patient in Brazil (24); and the TCC labo-
ratory strain (TCC) cloned from the continuous axenic culture of
T. cruzi isolated from an infected human patient in Chile (25).We
performed global protein expression profiling of the insect (epi-
mastigote) and infective (trypomastigote) stages of the three
strains to identify the proteins that might be differentially ex-
pressed in a stage- or strain-specific manner and contribute to
differences in the disease outcome. We validated the proteome
results by Western blotting and performed in vitro and in vivo
studies to look at the protein networks that might be responsible
for variations in parasites’ survival in macrophages and virulence
inmice. Our results suggested that a gene/protein expression pro-
file conducive to enhanced flagellar motility and peroxiredoxin-
dependent decomposition of macrophage-derived free radicals
provided survival andpersistence benefits toTcIDTU isolates.We
discuss the significance of our observations in relation to T. cruzi
modulation of host responses for ensuring its intracellular sur-
vival, dissemination, and persistence resulting in chronic disease.
MATERIALS AND METHODS
Parasites, cell culture, and mice. All chemicals were of molecular grade
and purchased from Sigma-Aldrich (St. Louis, MO) unless stated other-
wise. Epimastigotes of TcI strains of T. cruzi (COL, SYL, and TCC) were
cultured in liver infusion tryptose–10% fetal bovine serum (FBS)medium
supplemented with 25 g of hemin/ml, 100 U of penicillin/ml, and 100
mg of streptomycin/ml. T. cruzi trypomastigotes were maintained and
propagated by continuous in vitro passage in C2C12 cells. RAW 264.7
macrophages were cultured in Dulbecco modified Eagle medium high
glucose–10% FBS medium (Life Technologies, Grand Island, NY). Mac-
rophages were seeded in six-well (5 104/well), 12-well (2 104/well), or
96-well (0.5  104/well) plates or Nunc Lab-Tek II chamber slides (1 
104/well), infected with T. cruzi trypomastigotes (cell/parasite ratio, 1:3)
for 3 h, washed to remove free parasites, and then incubated according to
experimental requirements.
All animal experiments were performed according to the National
Institutes of Health Guide for the Care and Use of Experimental Animals
and approved by the institutional ethics committee at the Universidad
Nacional de Salta. Swissmice were bred at the animal facility at the School
of Health Science, National University of Salta, Salta, Argentina. T. cruzi
epimastigotes were incubated in the presence of 1% triatomine gut ho-
mogenate to facilitate differentiation to metacyclic trypomastigotes (26).
Complement-resistant metacyclic trypomastigotes were purified by incu-
bation of stationary culture in the presence of normal human serum.
Swiss mice (6 to 8 weeks old) were infected by intraperitoneal injection
with T. cruzi (104 metacyclic trypomastigotes per mouse). Survival from
infection was monitored daily, and blood parasitemia was monitored at
2-day intervals for up to 56 days postinfection (p.i.). Mice were sacrificed
in the chronic disease phase (120 days p.i.), and blood and tissue sam-
ples (heart, skeletal muscle) were harvested and stored at80°C.
Histology. Tissue sections were fixed in 10% buffered formalin for 24
h, dehydrated in absolute ethanol, cleared in xylene, and embedded in
paraffin. Then, 5-m sections of the heart and skeletal muscle tissue (3
tissue sections/organ/mouse) were stained with hematoxylin and eosin
(H&E) and evaluated by two observers in a blinded fashion by light mi-
croscopy using an Olympus BX-15 microscope (Center Valley, PA)
equipped with a digital camera and Simple PCI software (v.6.0; Compix,
Sewickley, PA). Inflammatory lesions (myocarditis) were scored as fol-
lows: 0, absent; 1, focal ormild with1 foci; 2, moderate with2 inflam-
matory foci; 3, severe with extensive generalized coalescing of inflamma-
tory foci or disseminated inflammation; or 4, diffused inflammation with
severe tissue necrosis, interstitial edema, and loss of integrity (27). Inflam-
matory infiltrate was characterized as diffused or focal depending upon
how closely the inflammatory cells were associated. The parasitic or in-
flammatory foci in skeletal muscle and heart tissue sections were scored as
follows: 0, absent; 1, 0 to 1 foci; 2, 1 to 5 foci; and 3,5 foci.
T. cruzi homogenates, two-dimensional electrophoresis (2DE), and
image analysis. T. cruzi epimastigotes or trypomastigotes were washed
with cold phosphate-buffered saline and lysed in 7 M urea, 2 M thiourea,
4% CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-propane-
sulfonate}, 12 mM EDTA, and 40 mM Tris (pH 7.6) containing protease
inhibitor cocktail (1 mM phenylmethylsulfonyl fluoride, 0.001 mM pep-
statin, and 0.1 mM leupeptin). Parasite pellets were added to the lysis
buffer (1 g [wet weight] per 3 ml of lysis buffer), vortexed for 3 min,
incubated on ice for 10 min, and centrifuged at 1,000  g for 5 min to
remove the cell debris. Protein concentrations were determined by using
a Bio-Rad protein assay (Bio-Rad, Hercules, CA).
T. cruzi lysates (100 g of protein) were separated by 2DE, employing
an IPGphormultiple sample isoelectric focusing (IEF) device (GEHealth-
care, Little Chalfont, United Kingdom) in the first dimension and a Cri-
terion Dodeca cell (Bio-Rad) in the second dimension, as described pre-
viously (28). Briefly, samples were loaded onto 11-cm dehydrated,
precast, immobilized pH gradient (IPG) strips (pH 3 to 10 and pH 5 to 8;
Bio-Rad), and the strips were rehydrated overnight in 1 M thiourea, 8 M
urea, 2% CHAPS, 1% dithiothreitol, and 0.2% ampholyte rehydration
buffer containing 0.002% bromophenol blue. The IEF was performed at
20°C using the following parameters: 50 V, 11 h; 250 V, 1 h; 500 V, 1 h;
1000 V, 1 h; 8,000 V, 2 h; and then at 8,000 V (for a total of 50,000 V). The
IPG strips were transferred to equilibration buffer (50 mM Tris-HCl [pH
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6.8], 6 M urea, 20% glycerol) and sequentially incubated for 15 min each
in the presence of 2% dithiothreitol–2% sodium dodecyl sulfate (SDS;
reducing conditions) and 2.5% iodoacetamide–2% SDS (alkylating con-
ditions). Equilibrated IPG strips were subjected to 2DE by using 8 to 10%
linear gradient precast Tris-HCl gels (Bio-Rad) in Tris-glycine-SDS buffer
(25 mM Tris-HCl, 192 mM glycine, 0.1% SDS [pH 8.3]). Electrophoresis
was performed on a Protean plus Dodeca cell system at 75 V for 1 h and
then at 120 V until the dye front reached the bottom of the gel.
Gels were fixed in 10%methanol–7% acetic acid, stained with SYPRO
Ruby (Bio-Rad), and destained in 10% ethanol–7% acetic acid to remove
the background. Gel images were acquired at an excitation wavelength of
488 nm and an emission wavelength of 560 nm by using a high-resolution
ProXPRESS proteomic imaging system (Perkin-Elmer, Waltham, MA).
The exposure time was adjusted to achieve a value of 55,000 to 63,000
pixel intensity (16-bit saturation) from the most intense protein spots on
the gel (28).
All 2D gels, representing at least four samples per stage (epimastigote
and trypomastigote) from the COL, SYL, and TCC isolates, were scanned
and analyzed with the Progenesis SameSpots software 2.0 (NonLinear
Dynamics, Durham, NC). After manual and automated pixel-to-pixel
alignment, the program performed automatic spot detection on all im-
ages. Normalized spot volumes, i.e., the volume of each spot over the
volume of all spots in the gel, were used to compare the different groups,
and candidates were identified as protein spots that changed in expression
level by 2-fold versus their specific control. Statistical significance was
assessed by a two-tailed Student t test and analysis of variance test (anal-
ysis of variance [ANOVA]), and P values of 0.05 were considered sig-
nificant for comparisons between control and experimental data.
Mass spectrometry (MS) and protein identification. Selected spots
(1 mm) on the 2D gels containing the protein of interest were excised
and trypsin digested as described previously by us (29, 30). Briefly, gel
spots were incubated at 37°C for 30 min in 50 mMNH4HCO3 and dehy-
drated twice for 5min each time in 100l of acetonitrile, and the proteins
were digested in gel at 37°C overnight with 10 l of trypsin solution (1%
trypsin in 25mM ammonium bicarbonate). Peptide mixtures (1l) were
directly spotted onto a matrix-assisted laser desorption ionization–time
of flight (MALDI-TOF) tandem MS (MS/MS) target plate with 1 l of
alpha-cyano-4-hydroxycinnamic acid matrix solution (5 mg/ml in 50%
acetonitrile) and analyzed by using a MALDI-TOF/TOF ABI 4800 pro-
teomics analyzer (Applied Biosystems, Foster City, CA). The Applied Bio-
systems software package included 4000 Series Explorer (v3.6 RC1) with
Oracle Database Schema Version (v. 3.19.0) and Data Version (3.80.0) to
acquire and analyze MS and MS/MS spectral data. The instrument was
operated in positive ion reflectron mode with the focus mass set at 1,700
Da (themass range was 850 to 3,000Da). ForMS data, 2,000 to 4,000 laser
shots were acquired and averaged from each protein spot. A peptide
mixture with reference masses of 904.468, 1,296.685, 1,570.677, and
2,465.199 kDa was used for automatic external calibration. After MALDI
MSanalysis,MALDIMS/MSwas performedon several (5 to 10) abundant
ions fromeach sample spot. A 1-kVpositive-ionMS/MSmethodwas used
to acquire data under post-source-decay conditions. The instrument pre-
cursor selection window was 3 Da. For MS/MS data, 2,000 laser shots
were acquired and averaged from each sample spot. Automatic external
calibration was performed using reference fragment masses 175.120,
480.257, 684.347, 1,056.475, and 1,441.635 (28).
For protein identification, the MS and MS/MS spectral data were
searched against the National Center for Biotechnology Information,
UniProtKB/Swiss-Prot, and TryTryp databases (accessed on 21 July 2013)
using AB Sciex GPS Explorer (v.3.6) software in conjunction with MAS-
COT (v2.2.07) as described previously (28). Briefly, protein match prob-
abilities were determined by using expectation values and/or MASCOT
protein scores. TheMSpeak filtering included the indicated parameters—
mass range, 800 to 4,000 Da; minimum signal-to-noise ratio (S/N) filter,
10; mass exclusion list tolerance, 0.5 Da—and the mass exclusion list for
some trypsin and keratin-containing compounds included masses of
842.51, 870.45, 1,045.56, 1,179.60, 1,277.71, 1,475.79, and 2,211.1Da. The
MS/MS peak filtering included the following parameters: minimum S/N
filter, 10; maximum missed cleavages, 1; fixed modification of carbam-
idomethyl (C); variable modifications due to oxidation (M); precursor
tolerance, 0.2 Da; MS/MS fragment tolerance, 0.3 Da; mass, monoiso-
topic; and peptide charges,	1. The significance of a proteinmatch, based
on both the peptide mass fingerprint (PMF) in the MS and the MS/MS
data from several precursor ions, is presented as the expectation value.
The expectation value is the number ofmatcheswith equal or better scores
that are expected to occur by chance alone. The default significance
threshold is P 0.05; however, we used a stringent threshold of 103 for
protein identification: the lower the expectation value, the more signifi-
cant the score.
Western blotting. Polyclonal antibodies against T. cruzi cytosolic
tryparedoxin peroxidase (cTXNPx) andmitochondrial tryparedoxin per-
oxidase (mTXNPx) were obtained as described previously (31, 32). Poly-
clonal antibodies against the iron superoxide dismutase (FeSOD) iso-
forms, FeSODa and FeSODb, and the tryparedoxin isoforms, TXN I and
TXN II, were produced as described previously (31, 32).
T. cruzi epimastigotes (5 108 cells/ml) and trypomastigotes (1 109
cells/ml) were lysed in 10 mM Tris-HCl (pH 7.5), 5 mM EDTA, and 1%
Nonidet P-40 containing protease inhibitor cocktail (Sigma-Aldrich).
Parasite lysates (30g/10l) were mixed with equal volumes of 2 load-
ing buffer (100 mM Tris-Cl [pH 6.8], 4% SDS, 0.2% bromophenol blue,
20% glycerol, and 200 mM 
-mercaptoethanol). Samples were resolved
by 10% SDS-PAGE, and the proteins were transferred onto polyvi-
nylidene difluoride (PVDF) membranes by using a wet vertical Criterion
blotter (Bio-Rad). Membranes were blocked for 1 h with 5% nonfat dry
milk (Bio-Rad) in 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, and 0.05%
Tween 20. Antibodies were diluted in Tris-buffered saline (TBS; 25 mM
Tris-HCl [pH 7.6], 140 mMNaCl, and 3mMKCl) containing 1% bovine
serum albumin and 0.1% Tween 20. Membranes were incubated over-
night at 4°Cwith antibodies againstmTXNPx (1:2,000 dilution), cTXNPx
(1:5,000 dilution), FeSODa and FeSODb (1:2,000 dilution), and TXN1
and TXN2 (1:1,000 dilution). Membranes were then washed three times
in TBS and incubated for 1 h with horseradish peroxidase (HRP)-conju-
gated anti-rabbit IgG (1:10,000 dilution; Sigma-Aldrich). Signal was de-
veloped by using an enhanced chemiluminescence detection system (GE
Healthcare). Membranes were stained with Ponceau S to confirm equal
loading of samples. Images were visualized and digitized, and densitom-
etry analysis was performed on a Fluorchem HD2 system (Alpha Inno-
tech, Santa Clara, CA).
Parasite susceptibility to oxidants. Activated macrophages exert cy-
totoxic effects against microorganisms via NADPH oxidase-dependent
production of superoxide (O2˙
) that then produces stable and diffusible
H2O2 oxidant. The reaction of superoxide with nitric oxide produces
peroxynitrite (ONOO) that is a strong cytotoxic oxidant. To assess the
susceptibility of T. cruzi isolates to these oxidants, trypomastigotes were
distributed to 96-well plates (105/100 l/well), followed by incubation in
the presence of 250 M hydrogen peroxide (H2O2) or peroxynitrite
(ONOO). The selected concentrations of oxidants were chosen based
upon the dose response curves using 0 to 500 g of H2O2 and ONOO

that showed10% of SylvioX10 trypomastigotes died when treated with
the highest concentration for 2 h. alamarBlue (10% final concentration;
Invitrogen) was added, and its reduction by mitochondrial dehydroge-
nases of the live parasites, resulting in the formation of resazurin (red,
highly fluorescent; excitation, 560 nm/emission, 590 nm), wasmonitored
by using a SpectraMaxM5microplate reader (Molecular Devices, Sunny-
vale, CA). The results are expressed as the percentage of viability, which
was calculated as follows: (the mean fluorescence of parasites treated with
oxidants/the mean fluorescence of parasites untreated) 100.
Activation of macrophages by T. cruzi: oxidative/nitrosative burst
and cytokine release. RAW 264.7 macrophages were infected with T.
cruzi for 3 h (cell/parasite ratio, 1:3), washed with RPMI to remove free
parasites, and then incubated for 24, 36, or 48 h. The cells were incubated
Zago et al.
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with 10 M CM-H2DCF-DA (Molecular Probes, Eugene, OR), and its
oxidation by intracellular reactive oxygen species (ROS), resulting in the
formation of fluorescent dichlorodihydrofluorescein (DCF; excitation,
498 nm/emission, 598 nm), was monitored on a SpectraMax M5 micro-
plate reader. Fluorescence microscopy for intracellular DCF was per-
formed on an Olympus BX-15 microscope, and images were captured
with a mounted digital camera (magnification,40).
ROS release in culture supernatants from infected macrophages was
measured by an Amplex red assay. Briefly, supernatants (50 l) were
added in triplicate to 96-well, black flat-bottomplates andmixedwith 100
M Amplex red (Molecular Probes) and HRP at 0.3 U/ml. The HRP-
catalyzed Amplex red oxidation by H2O2, resulting in fluorescent resoru-
fin formation, was monitored at an excitation wavelength of 563 nm and
an emissionwavelength of 587 nm (standard curve, 50 nM to 5MH2O2)
(33).
The inducible nitric oxide synthase (iNOS) activity was monitored by
the Griess reagent assay by using a nitrate/nitrite colorimetric assay kit
(Cayman, Ann Arbor, MI). Briefly, culture supernatants (80 l) were
reduced by the addition of 0.01 U of nitrite reductase, and 100 l of 1%
sulfanilamide made in 5% phosphoric acid–0.1% N-(1-naphthyl) ethyl-
enediamine dihydrochloride (1:1 ratio [vol/vol]) was added. After incu-
bation for 10 min, the formation of diazonium salt was monitored at 545
nm (standard curve, 2 to 100 M sodium nitrite). Culture supernatants
from infectedmacrophages were also utilized tomeasure secreted gamma
interferon (IFN-), tumor necrosis factor alpha (TNF-), and interleu-
kin-6 (IL-6) cytokines by using optEIA enzyme-linked immunosorbent
assay (ELISA) kits (Pharmingen, San Diego, CA), according to the man-
ufacturer’s specifications.
Parasite replication and release inmacrophages.RAW264.7macro-
phages were cultured in 12-well plates, infected with T. cruzi isolates for 3
h, washed to remove free parasites, and then incubated for 6, 12, or 18 h.
Total DNA was isolated from infected and uninfected macrophages by
using a QIAampDNAminikit (Qiagen, Chatsworth, CA). The total DNA
(50 ng) was used as a template, and real-time PCR performed on an
iCycler thermal cycler with SYBR green Supermix (Bio-Rad) and Tc18S-
specific (forward, 5=-TAGTCATATGCTTGTTTC-3=; reverse, 5=-GCAA
CAGCATTAATATACGC-3=) oligonucleotides. Data were normalized to
murine GAPDH (glyceraldehyde-3-phosphate dehydrogenase; forward,
5=-TGTGATGGGTGTGAACCACGAGA-3=; reverse, 5=-GAGCCCTTCC
ACAATGCCAAAGT-3=), and the fold change in T. cruzi burden calcu-
lated as 2CT, where CT represents the CT (sample)  the CT (con-
trol) (27). To assess parasite release, metacyclic trypomastigotes derived
from stationary-phase epimastigote cultures of the different T. cruzi iso-
lates were added to RAW 264.7 macrophages, and the trypomastigote
release in the supernatant wasmonitored for 2 weeks by lightmicroscopy.
Data analysis. Data (means the standard deviations) were derived
from at least three independent experiments (triplicate observations per
experiment) performed on different days. All data were analyzed by using
Prism 5 (GraphPad Software, La Jolla, CA). Data were tested for normal
distribution by histogram and Q-Q test and analyzed by using a Student t
test (comparison of two groups), and one-way analysis of variance
(ANOVA)with Tukey’s test (comparison ofmultiple groups). The level of
significance was accepted at P 0.05.
RESULTS
We used a well-established experimental model to assess the vir-
ulence of TcI isolates of T. cruzi. Swiss mice infected with SYL
exhibited patent blood parasitemia that peaked at 21 to 28 days p.i.
and was controlled by day 49 p.i. (Fig. 1A). Mice infected with
COL exhibited a delayed and up to 2-fold lower level of peak
parasitemia compared to that noted in SYL-infected mice (P 
0.01 [t test]). In comparison,mice infectedwith TCC exhibited no
detectable parasitemia by light microscopy, although blood PCR
for Tc18SrDNA (Fig. 1A) and hemoculture (data not shown) con-
firmed that mice were infected. Normal Swiss mice were used as
controls in all experiments.
Elicitation of inflammatory response is important for control
of acute T. cruzi infection, but its chronic persistence can contrib-
ute to tissue injury (27). Histological studies were performed in
chronic stage (120 days p.i.) to assess the tissue inflammation
andmyocarditis. The inflammatory fociwere observed in all tissue
sections (heart and skeletal muscle) of COL- and SYL-infected
mice. Representative images of H&E-stained heart tissue sections
are presented in Fig. 1B. Mice infected with COL isolate (versus
normal/uninfectedmice) exhibited extensive and diffused inflam-
mation consisting mainly of interstitial inflammatory infiltrate
throughout the heart (histological score, 2.75 0.4 versus 0.3
0.03; P 0.05 [t test]; Fig. 1Ba) and skeletal muscle (histological
score, 3 0.43 versus 0.32 0.03;P 0.05 [t test]) tissue sections.
The extent of inflammatory infiltrate in the heart tissue (score,
2.5  0.45; Fig. 1Bb) and skeletal muscle (score, 3  0.33) of
SYL-infected mice was not statistically different than that ob-
served inCOL-infectedmice. The degeneration ofmuscle fibers in
the heart (Fig. 1B) and skeletal muscle tissue (data not shown) of
COL- and SYL-infected mice was also evident. The TCC-infected
mice exhibited no overt tissue pathology and minimal inflamma-
tory infiltrate (histological score, 0.25  0.03 and 0.5  0.053 in
heart and skeletal muscle, respectively) that was significantly
lower than that noted in COL- and SYL-infected mice (P  0.05
[ANOVA-Tukey]; Fig. 1Bc). These data suggested that COL and
SYL (but not TCC) strains elicited blood parasitemia during the
acute infection period and persistent inflammatory infiltrate and
injury in the myocardium and skeletal tissue during the chronic
phase. The extent of blood parasitemia was not directly correlated
with chronic persistence of the parasite in the tissues.
FIG 1 Biological behavior of selected TcI isolates of T. cruzi in mice. Swiss
mice were infected with Colombiana (COL), Sylvio X10 (SYL), and TCC
strains of T. cruzi (n  6 per group), as described in Materials and Methods.
(A) Blood parasitemia was monitored by light microscopy (10 microscopic
fields per sample). (B) Representative H&E staining (blue, nuclear; pink,
muscle, cytoplasm, or keratin) of heart tissue sections from COL-, SYL-,
and TCC-infected mice, harvested during the chronic disease phase (120
days postinfection [p.i.]; magnification, 10). In all figures, data are pre-
sented as means  the SD, and significance is indicated as follows: *, P 
0.05; **, P  0.01; and ***, P  0.001.
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To begin to understandwhyTcI isolatesmay exhibit a differing
virulence in mice, we performed proteomic analysis of the infec-
tive trypomastigotes of COL, SYL, and TCC isolates. The pro-
teome profile of the epimastigote (insect, replicative) stage was
included to evaluate whether changes in the proteome profile are
stage or strain specific. In initial analysis, when using pH 3 to 10
strips, most of the proteins were resolved in the middle or on the
acidic side of the second-dimension 8 to 16% gradient gel (data
not shown). The narrow-range IPG strips (pH 5 to 8) yielded
enhanced resolution of T. cruzi proteins and detection of 2-fold-
more spots than were detected by using other IPG strips. We
therefore used pH 5 to 8 IPG strips for developing the proteome
profile of COL, SYL, and TCC strains (n 4 per sample). Repre-
sentative gel images for the epimastigote (Fig. 2Aa to c) and try-
pomastigote (Fig. 2Ba to c) forms of eachT. cruzi strain are shown
in Fig. 2. All protein spots were within the relative molecular size
of 10 to 250 kDa.
The 2D gel images were assessed for quality control by Same-
Spots software, and gel images were aligned both manually and
automatically against the reference epimastigote stage and trypo-
mastigote stage gels (Fig. 3). Spot boundaries were then detected
to identify the protein spots reproducibly found in all samples
within a group, as well as those that were differentially abundant
between any two groups. On average, 1,153, 1,347, and 1,106 pro-
tein spots were observed in epimastigotes, and 1,463, 1,172, and
1,475 protein spots were observed in trypomastigotes of COL,
SYL, and TCC isolates, respectively.
For the purpose of selecting protein spots for identification by
MS, the data sets were analyzed in a pairwise manner by a t test
withWelch’s correction that accounts for unequal variances. This
FIG 2 Proteomic profiling of TcI strains ofT. cruzi by 2DE. Epimastigote (A) and trypomastigote (B) stages ofT. cruziCOL, SYL, and TCC strains were cultured
as described in Materials and Methods. Parasite lysates were separated in the first dimension by IEF on 11-cm linear, pH 5 to 8 immobilized pH gradient strips,
and in the second dimension by SDS-PAGE on an 8 to 10% gradient gel. Gel images were obtained by using a high-resolution ProXPRESS proteomic imaging
system. Representative gel images of protein lysates from COL (Aa and Ba), SYL (Ab and Bb), and TCC (Ac and Bc) are shown.
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analysis yielded 55, 47, and 30 differentially abundant protein
spots (fold change,2.0; P 0.05 [t test]) in COL-versus-SYL,
SYL-versus-TCC, and COL-versus-TCC epimastigotes, respec-
tively. Likewise, we identified 50, 33, and 40 differentially
abundant protein spots (fold change,2.0; P 0.05 [t test]) in
COL-versus-SYL, SYL-versus-TCC, and COL-versus-TCC try-
pomastigotes, respectively. These protein spots were subjected
to MALDI-TOF MS/MS analysis, and homology searches were
conducted against theTryTrypdatabase for protein identification.
The protein spots that were differentially abundant in epimastigotes
and trypomastigotes of COL, SYL, or TCC (fold change,2.0, P
0.05) and identifiedwith high confidence (E value 0.001) are listed
in Tables 1 and 2, respectively.
Bioinformatics analysis using SMART and TARGET software
showed that several of the proteins that participate in host cell
invasion (e.g., cysteine peptidases, surface glycoprotein gp82, and
cruzipain) and cytoskeletal remodeling and motility (e.g., - and

-isoforms of actin and tubulin, cofilin-1, KMP11, and parafla-
gellar rod proteins) were significantly increased in abundance in
both the epimastigote and trypomastigote stages of the SYL and
COL compared to that noted in the TCC strain (Tables 1 and 2).
The antioxidant proteins involved in redox homeostasis (e.g.,
tryparedoxin peroxidases, peroxiredoxins, thioredoxin-depen-
dent peroxide reductase [PRDX3], and iron superoxide dismuta-
ses [FeSODa/b]) were primarily increased in abundance in the
trypomastigote stage of the SYL and COL compared to that noted
in TCC trypomastigotes (Table 2).
We chose to confirm the expression profile of the antioxidant
proteins because these exhibited a differential abundance in a
stage- (epimastigote versus trypomastigote) as well as strain-spe-
cific manner. Parasite lysates were probed by using antibodies
against cytosolic (cTXNPx) and mitochondrial (mTXNPx) iso-
forms of tryparedoxin peroxidase, tryparedoxin isoforms TXN I
andTXN II, and iron superoxide dismutase isoforms FeSODa and
FeSODb (31, 32). Due to the finding of a differential abundance of
-tubulin and
-actin inT. cruzi isolates (Table 1 and Table 2), we
could not use these proteins for normalizing the antioxidant pro-
tein content. Instead, equal protein loading was confirmed by
Ponceau S staining of the PVDF membranes, as before (34). Rep-
resentative Western blot images and densitometry evaluation of
the protein abundance in the epimastigote stage of the Tc1 isolates
are shown in Fig. 4. The cTXNPx expressionwas increased by 46%
in COL epimastigotes (versus TCC, P 0.05 [ANOVA-Tukey]),
whereas the abundance of all other members of the tryparedoxin
family and FeSOD isoforms was not changed significantly in the
epimastigote stage of the three TcI isolates (Fig. 4A and B). The
Ponceau S-stained gel image (Fig. 4C) confirmed equal loading of
all samples.
The expanded views of the corresponding spot for FeSOD and
TXNPx from representative 2D gel images of SYL and TCC try-
pomastigotes are shown in Fig. 5A. As determined by Western
blotting, COL and SYL trypomastigotes exhibited increases in the
protein levels of cTXNPx (2.5- and 2-fold, respectively; P 0.05
[ANOVA]), mTXNPx (32 and 28%, respectively; P 0.05 to 0.01
[ANOVA]); TXN I (2.0- and 2.14-fold, respectively; P  0.01),
TXN II (39.7 and 31.5%, respectively; P  0.05 [ANOVA]); and
FeSODa (33.1 and 49.5%, respectively; P 0.05 [ANOVA]) com-
pared to that noted in TCC trypomastigotes (Fig. 5B and C). The
protein level of FeSODb was not statistically different in trypo-
mastigotes of the three isolates. The Ponceau S-stained gel image
(Fig. 5D) confirmed equal loading of all samples. Together, the
results presented in Fig. 4 and 5 validate the 2DE/MS findings and
suggest that the antioxidant network was upregulated in the try-
pomastigote stage of the virulent TcI isolates (COL and SYL) of T.
cruzi.
To assess the biological significance of the antioxidant status in
TcI isolates, we took a three-pronged approach. First, we sought to
determine whether the selected TcI strains differed in their ability
to resist exogenous oxidative/nitrosative stress (Fig. 6). Trypo-
mastigotes were challenged for 2 and 4 hwith biologically relevant
doses of H2O2 and ONOO
, the main oxidants present in the
phagosomal environment (35, 36), and parasite viability was de-
termined by an alamarBlue assay. Up to 84.9, 95.7, and 66.8% of
COL, SYL, and TCC trypomastigotes, respectively, were viable
after H2O2 treatment for 2 h, and their viabilities were not further
decreased after 4 h (Fig. 6A). Likewise, 80.6, 93.2, and 49.7%, of
COL, SYL, and TCC trypomastigotes, respectively, were viable
after ONOO treatment for 2 h, and parasite viability was not
further reduced at 4 h (Fig. 6B). In comparison to TCC, the SYL
and COL isolates exhibited significantly higher levels of resistance
to exogenousH2O2 (27 and 46%, respectively;P 0.01 [ANOVA-
FIG 3 Identification of differentially abundant protein spots inT. cruziTcI strains. Protein spots that exhibited significant changes in abundance in epimastigote
(A) and trypomastigote (B) stages of COL and SYL (versus TCC, P 0.05) are marked on representative gel images of SYL lysate. Protein spots were subjected
to MALDI-TOF MS analysis for protein identification (see Tables 1 and 2).
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TABLE 1 Protein spots that were differentially expressed in epimastigote stage of TcI isolates of T. cruzia
Protein spot Protein name (gene) NCBI accession no.
Mol mass
(Da)
Peptide
count
Protein
score
Protein
score
(CI%) pI E value
Spots conserved in the three isolates
1 Chain A, tyrosine aminotransferase (TcTAT) gi|6137418 46,120.3 12 188 100 5.72 3.155E–13
3 Tyrosine aminotransferase (TcTAT) gi|71407311 46,238.5 13 442 100 5.82 1.256E–38
4 Tyrosine aminotransferase N-term (TcTAT) gi|71655339 27,698.9 12 400 100 5.71 1.991E–34
5 L-Tyrosine:2-oxoglutarate aminotransferase (TcTAT) gi|1168606 46,137.4 20 737 100 5.82 3.972E–68
6 Tyrosine aminotransferase (TcTAT) gi|71413938 46,100.4 16 537 100 5.66 3.972E–48
7 NADPH flavin oxidoreductase (old yellow enzyme,
TcOYE)
gi|61741942 42,191.6 19 902 100 6.03 1.256E–84
8 NADPH flavin oxidoreductase (old yellow enzyme,
TcOYE)
gi|61741950 42,233.6 18 889 100 5.97 2.506E–83
9 L-Threonine 3-dehydrogenase (TcTDH) gi|71406160 36,880.7 8 181 100 6.71 1.581E–12
10 NADPH flavin oxidoreductase (old yellow enzyme,
TcOYE)
gi|61741952 42,080.5 20 749 100 6.03 2.506E–69
11 Aldo-keto reductase/quinone oxido-reductase (AKR) gi|189396135 32,485.5 13 499 100 7.18 1.256E–43
12 Aldo-keto reductase/quinone oxido-reductase (AKR) gi|14279174 31,764.2 13 376 100 8.58 2.506E–31
Protein spots differentially expressed in COL (compared to TCC)
13 Proline racemase B (TcPRACB) gi|74812220 38,440.6 12 442 100 5.44 1.256E–38
14 Proline racemase N-term (TcPRACB) gi|71400794 32,411.5 11 435 100 5.63 6.295E–38
15 Major paraflagellar rod protein 2 (TcPAR2) gi|162179 69,504.9 19 355 100 5.85 6.295E–30
16 Paraflagellar rod protein N-term (TcPAR) gi|71411387 42,471.9 16 355 100 6.12 6.295E–30
17 Paraxonemal (paraflagellar) rod protein (TcPAR2) gi|71398801 31,336.1 10 164 100 5.95 7.924E–11
18 2-Hydroxyacid dehydrogenase N-term, D-isomer
(2-Hacid-dh)
gi|71406187 28,516.7 16 567 100 6.17 3.972E–51
20 Short interspersed repetitive element (TcSIRE) gi|1911172 11,565 10 530 100 5.08 1.991E–47
21 2-Hydroxyacid dehydrogenase, D-isomer
(2-Hacid-dh)
gi|71406189 22,228.2 11 296 100 5.87 5E–24
23 HpcH/HpaI aldolase (TcP28) gi|4558456 29,886.2 7 156 100 6.06 5E–10
24 Pyridoxal kinase (TcPDXK) gi|71418579 33,273.6 4 125 100 5.93 6.295E–07
25 NADP-dependent malic enzyme N term (TcME1) gi|71662506 62,705.5 12 307 100 6.55 3.972E–25
26 NADP-dependent malic enzyme N term (TcME1) gi|71651465 62,634.4 14 300 100 6.37 1.991E–24
27 Cytochrome c oxidase subunit IV (TcCOXIV) gi|71660419 38,924.4 16 351 100 5.72 1.581E–29
28 Tryparedoxin peroxidase (TcTXNPx) gi|17224953 22,246.1 11 413 100 5.96 9.976E–36
29 Tryparedoxin peroxidase (TcTXNPx) gi|71399514 22,375.1 11 411 100 6.32 1.581E–35
30 Tryparedoxin peroxidase (TcTXNPx) gi|4388655 25,545.3 22 167 100 7.56 2.506E–28
31 Calpain-like cysteine peptidase (TcCAPN1) gi|71411006 12,798.3 6 179 100 5.07 1.256E–11
32 Beta tubulin of T. cyclops (TcTUBB) gi|91983197 44,496.8 13 410 100 5.68 1.991E–35
33 Beta tubulin of T. danilewskyi (TdTUBB) gi|74229926 49,695.8 12 391 100 4.74 1.581E–33
34 Alpha tubulin of T. cyclops (TcTUBA) gi|91983196 49,777.5 19 677 100 4.93 1.991E–61
35 Alpha tubulin of T. brucei (TbTUBA) gi|115504283 49,755.5 21 646 100 4.93 2.506E–58
36 Elongation factor 1 (TcEF1A) gi|71408910 49,083.4 19 416 100 8.93 5E–36
37 Ribokinase (TcRBKS) gi|71659743 35,262.6 7 158 100 6.95 3.155E–10
38 Heat shock protein 70 partial (TcHSP70) gi|10626 74,233.7 31 626 100 5.64 2.506E–56
39 Heat shock protein HSP70 (TcHSP70) gi|162117 71,210.1 30 623 100 5.42 5E–56
40 Heat shock 70-kDa protein, mitochondrial
(TcHSP70-10)
gi|71407515 70,946 24 516 100 5.75 2.506E–45
Spots differentially expressed in SYL (compared to TCC)
53 Cytochrome c oxidase subunit IV (TcCOXIV) gi|71667854 38,884.4 15 339 100 5.72 2.506E–28
54 Tryparedoxin peroxidase (TcTXNPx) gi|71413207 22,376.1 10 357 100 5.69 3.972E–30
55 Tryparedoxin peroxidase (TcTXNPx) gi|4388655 25,506.1 6 134 100 7.62 7.924E–08
56 Elongation factor alpha G5 (TcEFA-G5) gi|52424046 49,067.4 18 405 100 8.93 6.295E–35
57 Heat shock protein 70 (TcHSP70) gi|50659756 71,329.9 30 524 100 5.06 3.972E–46
58 Glucose-regulated protein 78 (TcHSPA5 or TcGRP78) gi|71415505 71,271.9 29 510 100 5.09 9.976E–45
59 Glucose-regulated protein 78 (TcHSPA5 or TcGRP78) gi|349838 71,488 25 365 100 5.07 3.155E–30
75- to 77-kDa antigen (TcHSP70) gi|1097750 41,716.5 17 273 100 4.99 5E–21
60 Mitochondrial heat shock protein (TcHSP70mt) gi|205278870 70,969.1 25 527 100 5.87 1.99E–46
61 Heat shock protein 70 (TcHSP70) gi|205278868 71,193 26 517 100 5.32 2.51E–73
(Continued on following page)
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Tukey]) and ONOO (64.5% and 2.1-fold, respectively; P 
0.001 [ANOVA-Tukey]) stress (Fig. 6).
Next, we sought to determine whether TcI isolates exhibited
differing capacities tomodulate intracellular oxidative/nitrosative
stress. For this, macrophages were incubated with T. cruzi trypo-
mastigotes for 24, 36, and 48 h, and the intracellular ROS was mea-
sured by using a CM-H2DCF-DA fluorescence probe. Macrophages
infected with COL and SYL for 24 h exhibited minimal intracellular
DCFfluorescence,whileTCC-infectedmacrophages demonstrated a
significant increase in DCF fluorescence compared to that noted in
normal controls (Fig. 7A, compare panels a and b to panel c). A
similar pattern of increased intracellular DCF fluorescence in TCC-
infected macrophages, compared to COL- or SYL-infected macro-
phages, was observed at 36 h and 48 h p.i. (data not shown).
Subsequently, we measured the release of H2O2 (Amplex red
assay) and nitrate/nitrite (Griess assay) from the infected macro-
phages. The H2O2 levels in supernatants of macrophages infected
with COL and SYL isolates for 24 or 48 h were not statistically
different from that noted in normal controls (Fig. 7B). TCC-in-
fected (versus SYL- or COL-infected) macrophages exhibited up
to 1.5- and 2.3-fold increases inH2O2 levels at 24 and 48 h, respec-
tively (Fig. 7B; all, P 0.01 [ANOVA-Tukey]). The nitrate/nitrite
release, an indicator of iNOS activity, was increased by 1.6- to
2.7-fold, 1.7- to 2.9-fold, and 3.7- to 21-fold in COL-, SYL-, and
TCC-infected macrophages, respectively (Fig. 7C). The maximal
difference in nitrate/nitrite level between COL- and SYL-infected
versus TCC-infected macrophages was noted at 24 h p.i. (Fig. 7C,
P 0.001 [ANOVA-Tukey]).
To verify that macrophages infected with TCCmay simply not
be activated, we monitored cytokine (IFN-, TNF-, and IL-6)
release in the supernatants of infected cells by an ELISA. These
data showed that, irrespective of the parasite strain used, patent
increases in TNF- (33.5- to 35.5-fold) and IL-6 (100-fold) re-
lease were mounted by macrophages within 24 h p.i., and the
cytokine releasewasmaintained at 36 and 48 h p.i. (Fig. 7D andE).
No increase in IFN- release was observed in any of the infected
macrophages. Together, the data presented in Fig. 7 suggested that
COL and SYL (versus TCC) trypomastigotes faced compromised
oxidative and nitrosative stress inmacrophages. The differences in
antioxidant capacity of the parasite isolates had no effect on cyto-
kine signaling in macrophages.
Finally, we sought to determine whether the differential abun-
dance of antioxidants conferred a survival advantage to COL and
SYL trypomastigotes in macrophages. For this, RAW 264.7 mac-
rophages were infected with T. cruzi isolates for 6, 12, and 18 h.
Infected cells were submitted to Giemsa staining, and200 cells/
slide (triplicate experiments) were evaluated by light microscopy
to determine the number of infected macrophages. We observed
no statistically significant difference in the parasite uptake bymac-
rophages incubated with COL, SYL, or TCC isolates (data not
shown). A quantitative measure of intracellular parasites by real-
time quantitative PCR showed a significant increase in intracellu-
lar SYL, followed by COL and TCC, from 0 to 18 h p.i. (Fig. 8A).
The rapid replication of SYL in macrophages was evidenced by
detection of Tc18SrDNA signal that was 12.6- to 13.5-fold
and 27-fold higher than that noted in COL- and TCC-in-
fected macrophages, respectively, from 6 to 12 h p.i. (P 0.01 to
0.001 [ANOVA-Tukey]). By 18 h p.i., intracellular COL level was
7.6-fold higher than that noted for TCC (P  0.01 [t test]) but
lagged behind that of SYL by 3.2-fold (P 0.01 [t test]).
We used metacyclic trypomastigotes derived from stationary-
phase epimastigote cultures of COL, SYL, and TCC isolates to
monitor their ability to escape from macrophages. For this, para-
sites were added to monolayers of RAW 264.7 macrophages and,
after infection for 3 h, the cells were washed and incubated for 2
weeks. The hemacytometer counting of parasites in supernatants
TABLE 1 (Continued)
Protein spot Protein name (gene) NCBI accession no.
Mol mass
(Da)
Peptide
count
Protein
score
Protein
score
(CI%) pI E value
62 Alpha tubulin (TcTUBA) gi|71397525 49,767.5 22 806 100 4.94 2.51E–74
62 Alpha tubulin (TcTUBA) gi|1314208 46,927.4 20 787 100 5.49 1.99E–72
63 Beta tubulin 1.9 (TcTUBB) gi|18568139 49,667.8 16 643 100 4.74 5.00E–58
64 Beta tubulin of T. cyclops (TcTUBB) gi|91983197 44,496.8 14 626 100 5.68 2.51E–56
65 Calpain-like cysteine peptidase (TcCAPN1) gi|71409962 12,839.3 5 170 100 5.08 1.26E–11
66 Tryparedoxin peroxidase family (TcGPX1) gi|19171158 16,057.1 5 102 99.9 5.27 9.98E–51
67 Histone H2B of T. brucei (TbHIST1H2B) gi|71748436 12,588.8 4 84 96.1 11.77 1.26E–54
68 Beta tubulin (TcTUBB) gi|71656281 49,667.7 15 570 100 4.7 9.51E–56
69 Alpha tubulin of T. danilewskyi (TdTUBA) gi|74229924 49,765.6 21 722 100 4.94 6.29E–66
70 Cofilin-actin depolymerizing factor (TcCFL1) gi|71417693 15,735.8 9 300 100 5.69 9.98E–24
71 Prostaglandin F synthase (TcPGFS) gi|71651365 32,489.5 16 532 100 7.71 6.29E–47
72 Hypothetical protein gi|71657351 129,881.1 18 77 79.8 6.84 7.92E–41
73 Lipophosphoglycan biosynthetic protein (TcLPG3) gi|71663313 86,968.5 17 248 100 5.26 1.58E–18
74 3-Hydroxy-3-methylglutaryl coenzyme A synthase-
like (TcHMGCS2)
gi|71661816 54,719.2 14 445 100 6.17 3.15E–38
75 Carboxypeptidase (TcCPD) gi|71667929 57,626.9 19 136 100 5.92 2.51E–07
Metallocarboxypeptidase (TcCPD) gi|47076074 57,686.9 18 127 100 5.85 1.99E–06
a T. cruzi epimastigotes (COL, SYL, and TCC isolates) were cultured in LIT media. Protein homogenates were resolved by two-dimensional gel electrophoresis. Gel images were
analyzed on Progenesis SameSpots software, and normalized spot volumes were used to compare different groups. Proteins spots with a2-fold change were subjected to MALDI-
TOF MS/MS analysis. The number of peptides for each protein spot for which peptide mass fingerprint was obtained by MALDI-TOF MS is listed. Protein spots that were identified
with high confidence by Mascot search engine (a protein score of62) and statistically significant at the 95% confidence interval (CI%) are listed. The probability of match of the
peptides in database search was accepted as significant at an E value of0.001. pI, isoelectric pH. Underlined text indicates proteins involved in host cell invasion and cytoskeletal
remodeling and motility. Boldface text indicates proteins of the antioxidant family involved in redox homeostasis.
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TABLE 2 Protein spots that were differentially expressed in trypomastigote stage of TcI isolates of T. cruzia
Protein spot Protein name (gene)
NCBI
accession no.
Mol mass
(Da)
Peptide
count
Protein
score
Protein
score
(CI%) pI E value
Spots differentially expressed in COL isolate compared to TCC
1 Tryparedoxin peroxidase (TcTXNPx) gi|17224953 22,246.1 10 340 100 5.96 1.99054E–28
2 Tryparedoxin peroxidase (TcTXNPx) gi|71399514 22,375.1 10 304 100 6.32 3.97164E–24
5 Calpain-like cysteine peptidase (Tc CL) gi|71411006 12,798.3 5 164 100 5.07 7.92447E–11
6 Tryparedoxin peroxidase family (TcGPX1) gi|19171158 16,057.1 4 82 98.73 5.27 1.25674E–05
7 Paraflagellar rod protein 3 (TcPFR3) gi|2226084 68,705.3 24 288 100 5.86 3.15479E–23
8 Paraflagellar rod protein, 69 kDa (TcPFR) gi|71650963 69,518.9 26 215 100 5.85 6.29463E–16
9 Paraflagellar rod protein 2 (TcPFR2) gi|162179 69,504.9 24 198 100 5.85 3.15479E–14
10 Paraflagellar rod protein of T. brucei
(TbPFR-C/TbPFR-D)
gi|72387193 68,640.3 19 175 100 5.78 6.29463E–12
11 Heat shock protein 70 (TcHSP70/TcHSPA5) gi|50659756 71,329.9 33 877 100 5.06 3.97164E–82
12 Glucose-regulated protein, 78 kDa (TcGRP78) gi|349838 71,488 29 603 100 5.07 9.97631E–55
13 Alpha tubulin (TcTUBA) gi|71397525 49,767.5 19 405 100 4.94 6.29463E–35
14 Alpha tubulin (TcTUBA) gi|1314208 46,927.4 18 398 100 5.49 3.15479E–34
15 Beta tubulin of T. grayi (TgTUBB) gi|91983201 42,806.9 13 288 100 5.29 3.15479E–23
16 Beta tubulin of T. danilewskyi (TdTUBB) gi|74229926 49,695.8 13 281 100 4.74 1.58114E–22
17 Cytochrome c oxidase subunit IV (TcCOXIV) gi|71667854 38,884.4 15 339 100 5.72 2.50594E–28
18 Kinetoplastid membrane protein 11 (TcKMP11) gi|71413455 10,876.3 8 349 100 5.73 1.25594E–28
19 Kinetoplastid membrane protein 11 of T. rangeli
(TrKMP11)
gi|32892042 11,003.4 8 347 100 6.52 1.99054E–28
20 Phosphoglycerate kinase 1 (TcPGK1) gi|71411859 44,441.1 16 240 100 6.19 9.97631E–18
21 3-Phosphoglycerate kinase, glycosomal
(TcPGKC)
gi|71654900 54,867.6 15 122 100 6.94 6.29463E–06
22 Chain A, tryparedoxin peroxidase (TcTXNPx) gi|58176947 22,743.3 8 305 100 5.71 3.15479E–24
23 Peroxiredoxin, antioxidant oxidoreductase
(TcPRX)
gi|4388655 20,235.2 9 440 100 5.07 9.97631E–38
24 Ubiquitin precursor (TcUBQ) gi|162337 40,105.6 5 409 100 9.39 1.25594E–34
25 Fe-superoxide dismutase, chain A (TcFeSODa) gi|158428656 21,800.8 7 441 100 6.65 7.92447E–38
26 Fe-superoxide dismutase (TcFeSOD) gi|1066332 21,818.9 7 440 100 6.64 9.97631E–38
27 Calpain-like cysteine peptidase (TcCAPN1) gi|71409962 12,839.3 4 159 100 5.08 1.25594E–09
29 Ascorbate-dependent peroxidase (TcAPX) gi|24370982 31,855.2 7 269 100 6.69 1.25594E–20
Spots differentially expressed in SYL isolate compared to TCC
30 Beta tubulin of T. cyclops (TcTUBB) gi|91983197 44,496.8 14 295 100 5.68 6.29463E–24
31 Beta tubulin 1.9 (TcTUBB) gi|18568139 49,667.8 14 291 100 4.74 1.58114E–23
32 Prostaglandin F2 alpha synthase (TcPGFS) gi|71661165 14,648.3 4 119 100 6.05 2.50594E–06
33 Amidinotransferase-like (TcGATM) gi|71661567 43,051.9 9 184 100 6 7.92447E–13
34 Amidinotransferase-like (TcGATM) gi|71415202 28,667.4 5 128 100 5.21 3.15479E–07
35 10-kDa heat shock protein (TcHSPE1) gi|71425263 10,692.8 2 66 49.41 9.05 2.50594E–18
36 Tryparedoxin peroxidase, chain A (TcTXNPX) gi|58176947 22,743.3 9 328 100 5.71 3.15479E–27
37 Alpha tubulin of T. danilewskyi (TdTUBAi) gi|74229924 49,765.6 18 394 100 4.94 7.92447E–34
38 Tubulin alpha (TcTUBA) gi|3915082 49,696.5 17 358 100 4.9 3.15479E–30
39 NADPH flavin oxidoreductase (old yellow
enzyme, TcOYE)
gi|61741942 42,191.6 12 250 100 6.03 1.99054E–19
40 Glutamate dehydogenase (TcGLUD1) gi|71414987 41,680.5 11 239 100 7.1 2.50594E–18
41 Calmodulin (TcCALM1) gi|71407658 26,740.2 5 89 100 5.1 3.15479E–17
42 Cysteine peptidase inhibitor (TcSERPIN) gi|71664690 12,114 2 89 98.63 6.58 0.001256238
43 Ubiquitin homolog (TcUBQ) gi|10673 14,648.8 5 404 100 9.82 3.97164E–34
44 Vacuolar ATP synthase subunit B-like
(TcATP5B)
gi|70870795 104,474.5 30 656 100 5.75 2.50594E–59
47 Heat shock protein 85 (TcHSP85) gi|70876495 82,887.1 18 680 100 5.79 9.97631E–62
48 Ubiquitin-like (TcUBQ) gi|136677 8,503.6 5 427 100 6.56 1.99054E–36
49 Ubiquitin-like (TcUBQ) gi|10674 8,762.7 5 425 100 6.56 3.15479E–36
50 Kinetoplastid membrane protein 11 (TcKMP11) gi|6166388 9,923.9 8 351 100 6.58 7.92447E–29
51 Kinetoplastid membrane protein 11 of
T. rangeli (TrKMP11)
gi|24286543 11,048.4 8 349 100 5.96 1.25594E–28
52 Cysteine-protease inhibitor/Chagasin
(TcSERPIN)
gi|118137894 14,448 3 185 100 6.66 3.15479E–12
(Continued on following page)
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of infected cells at 7 days p.i. showed 36.8- and 24.3-fold-higher
levels of parasite release frommacrophages infectedwithCOL and
SYL isolates, respectively, compared to that observed in superna-
tants of TCC-infected macrophages (Fig. 8B, P  0.01 to 0.001
[ANOVA-Tukey]). By the end of the second week postinfection,
all cells infected with SYL and COL had ruptured, releasing para-
sites, whereas TCC-infected macrophages continued to exhibit
intracellular parasites (data not shown). These data suggested that
(i) macrophages were equally competent in their ability to phago-
cytose different isolates ofT. cruzi, (ii) COL and SYL (versus TCC)
were better equipped to survive and replicate inmacrophages, and
(iii) COL and SYL trypomastigotes succeeded in efficient release
from macrophages.
DISCUSSION
Reported cases of Chagas disease from Latin America have been
associated with TcI isolates (10, 11, 37, 38). It has been postulated
that TcI isolates exhibitmore tissue tropism than do other lineages
ofT. cruzi (39–41) and are therefore responsible for severe pathol-
ogy of the heart. In this context, we performed biological charac-
terization of threeT. cruzi isolates of the TcIDTUand showed that
COL, SYL, and TCC isolates exhibited differing growth and viru-
lence behavior in mice (Fig. 1). The striking difference in the in-
fectivity and disease severity pattern ofCOL and SYL versus that of
TCCmade them an ideal model for global proteomic profiling for
the identification of candidates involved with the mechanism of
parasite invasion, replication, and survival in the host cells.
The comparative proteome profiling of the three TcI strains
that exhibited different virulence levels inmice yielded novel find-
FIG 4 Western blotting for selected proteins of the antioxidant network in TcI
epimastigotes. (A) Homogenates of the COL, SYL, and TCC epimastigotes were
resolved by SDS-PAGE. Membranes were probed by using specific antibodies
against mitochondrial and cytosolic tryparedoxin peroxidases (mTXNPx and
cTXNPx, respectively), tryparedoxin substrates (TXN I and TXN II), and Fe2	
SODs (FeSODa and FeSODb). (B) Bar graphs show densitometric analysis of the
band intensities from Western blotting, normalized to total loaded protein. (C)
Ponceau S staining shows equal loading of all samples.
TABLE 2 (Continued)
Protein spot Protein name (gene)
NCBI
accession no.
Mol mass
(Da)
Peptide
count
Protein
score
Protein
score
(CI%) pI E value
53 Cysteine peptidase inhibitor (TcSERPIN) gi|71664690 12,114 2 127 100 6.58 1.99054E–06
54 Hypothetical protein (Tc CL) gi|71410630 12,677.5 2 71 23.03 6.58 1.99054E–12
55 Tryparedoxin peroxidase (TcTXNPX) gi|71413207 22,376.1 8 419 100 5.69 1.25594E–35
56 Thioredoxin-dependent peroxide reductase
(PRDX3)
gi|241785831 25,789.7 4 214 100 9.08 3.97164E–15
57 Iron superoxide dismutase (TcFeSOD) gi|71414374 23,339.6 7 439 100 6.7 1.25594E–37
58 Iron superoxide dismutase B (TcFeSODB) gi|2149612 21,745.8 6 285 100 6.37 3.15479E–22
59 Heat shock 70-kDa protein (TcHSP70) gi|71406304 40,831 18 720 100 6.19 9.97631E–66
60 Heat shock protein HSP70 (TcHSP70) gi|162117 71,210.1 19 685 100 5.42 3.15479E–62
61 Heat shock protein 70 (TcHSP70) gi|10626 74,233.7 17 609 100 5.64 1.25594E–54
62 Ubiquitin-conjugating enzyme-like (Tc CL) gi|71414042 15,754.8 9 157 100 5.81 1.99054E–09
63 Beta tubulin 1.9 (TcTUBB) gi|18568139 49,667.8 12 227 100 4.74 1.99054E–16
64 Beta tubulin (TcTUBB) gi|3915883 49,540.7 11 262 100 4.69 1.25594E–20
65 Alpha tubulin (TcTUBA) gi|1314208 46,927.4 18 400 100 5.49 9.97631E–34
66 Alpha tubulin (TcTUBA) gi|71397525 49,767.5 18 396 100 4.94 2.50594E–33
67 Calpain-like cysteine peptidase (TcCAPN1) gi|71411006 12,798.3 5 177 100 5.07 1.99054E–11
68 3-Phosphoglycerate kinase (TcPGK) gi|16945527 54,767.4 15 121 100 6.94 7.92447E–06
69 Phosphoglycerate kinase (TcPGKCL) gi|71411862 64,528.8 14 114 100 8.04 3.97164E–05
70 Tryparedoxin peroxidase (TcTXNPX) gi|17224953 22,246.1 9 492 100 5.96 6.29463E–43
71 Cruzipain gi|1136308 47,852.1 3 348 100 5.35 1.58114E–28
72 69-kDa paraflagellar rod protein (TcPFR) gi|71411387 42,471.9 18 153 100 6.12 9.97631E–10
73 Surface glycoprotein, 82 kDa (TcGP82) gi|6049148 59,591.9 20 170 100 6.05 9.97631E–11
a T. cruzi trypomastigotes (COL, SYL, and TCC isolates) were cultured in C2C12 cells. Parasite protein homogenates were resolved by two-dimensional gel electrophoresis. Gel
images were analyzed on Progenesis SameSpots software, and normalized spot volumes were used for comparison of different groups. Proteins spots with2-fold change were
subjected to MALDI-TOF MS/MS analysis. The significance of a protein match, based on the peptide mass fingerprint in the MS and the MS/MS data, is presented as expectation
values (P 0.01). pI, isoelectric pH. Underlined text indicates proteins involved in host cell invasion and cytoskeletal remodeling and motility. Boldface text indicates proteins of
the antioxidant family that are involved in redox homeostasis.
T. cruzi Proteome and Antioxidant Network
June 2016 Volume 84 Number 6 iai.asm.org 1851Infection and Immunity
 o
n
 M
ay 24, 2016 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
ings. One, the expression profiles of numerous proteins in COL
and SYL epimastigotes and trypomastigotes were consistent with
enhancedmotility and contractility. For example, upregulation of
-actin, -tubulin, 
-tubulin, cofilin-1, and KMP11 that are cen-
tral to remodeling of the cytoskeleton and modulation of cell
shape for migration (42, 43) was noted in COL and SYL (versus
TCC) strains (Tables 1 and 2). Likewise, members of the parafla-
gellar rod (PFR) and paraxonemal protein families, known to be
essential for flagellar wave frequency and amplitude and forward
motility of the parasite (reviewed in reference 44), were enhanced
in abundance in COL and SYL (versus TCC) strains. Further, SYL
and COL trypomastigotes also exhibited an increased abundance
of calpain-like cysteine peptidases, surface glycoprotein gp82, and
cruzipain that are involved in host cell attachment and invasion
(45, 46). We surmise that virulence of the COL, SYL, and possibly
other isolates of the TcI DTU is determined by themotility capac-
ity that ensures parasite transmission from triatomines and dis-
semination to tissues in the mammalian host. Indeed, several
studies using RNA interference against PFR2 in T. brucei have
shown that ablation of PFR2 resulted in sluggish parasites that
lacked cytokinesis capability and were monstrous in size, also
showing multiple nuclei, kinetoplasts, and flagella; these PFR2-
deficient cells were unable to survive in vitro or in vivo (47, 48).
Further studies will be required to validate the importance of cy-
toskeletal remodeling andflagellar function as new targets for pos-
sible intervention against T. cruzi infection.
Comparative proteome analysis of the two parasite forms
showed that the differentiation of epimastigotes to trypomastig-
otes was accompanied by a shift from histidine catabolism to glu-
tamate, a decline in ribosomal proteins, and an increase in the
expression level of a battery of antioxidant enzymes (compare
Tables 1 and 2). Three major families of peroxidases identified in
trypanosomatids included the 2-cysteine peroxiredoxins, as well
as the non-selenium glutathione and ascorbate peroxidases (49).
Notably, we showed a significant correlation between the abun-
dance of the antioxidant enzymes and the virulent behavior of the
COL and SYL trypomastigotes. The increase in tryparedoxin per-
doxidases occurred in infective trypomastigote and replicative
amastigote stages irrespective of the cell types (e.g., muscle cells in
this study, and LLC-MK2 and macrophages in other studies [34,
50]) used for culturing the parasites. Regeneration of the reduced
TXNPx depends on cytosolic (TXN I)- and membrane (TXN II)-
localized thioredoxin substrates (31, 51). Consistent with the in-
creased abundance of TXNPx, the TXN I level was also increased
in COL and SYL trypomastigotes (Fig. 5). COL and SYL trypo-
mastigotes also showed an increased abundance of the FeSODa
(mitochondrial) enzyme (Fig. 5). Others have also documented
the differential expression of peroxiredoxin and FeSOD proteins
of the antioxidant network in parasites in correlation with in vivo
infectivity and pathological behavior (32, 34, 52). The question
arises as to how the TXNPx/TXN antioxidant network is associ-
ated with the virulence of the TcI isolates of T. cruzi. One expla-
nation could be that, upon infection, T. cruzi faces the hostile
environment of phagocytes, and an increase in antioxidant re-
sponse would allow adaptation of the infective forms to the oxi-
FIG 5 Validation of expression profile of selected proteins of the antioxidant
network in the trypomastigote stage of TcI strains. (A) Expanded views of the
corresponding spots for TXNPx (23 kDa) and FeSOD (21 kDa) from repre-
sentative 2D gel images of SYL and TCC trypomastigotes are shown. (B) Ho-
mogenates of COL, SYL, and TCC trypomastigotes were resolved by SDS-
PAGE. Membranes were probed by using specific antibodies against
mitochondrial and cytosolic tryparedoxin peroxidases (mTXNPx and
cTXNPx, respectively), tryparedoxin substrates (TXN I and TXN II), and Fe2	
SODs (FeSODa and FeSODb). (C) The band intensities from Western blot
images were digitized and normalized to total protein loaded. (D) Ponceau S
staining shows equal loading of all samples.
FIG 6 Variable resistance of TcI strains to oxidants. The COL, SYL, and TCC
trypomastigotes were in vitro incubated with 250 M H2O2 (A) or 250 M
ONOO (B). Parasite viability was determined at 2 and 4 h postincubation by
an alamarBlue assay. Data are presented as the percentage of viability with
respect to untreated parasites.
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dative environment of phagocytic cells in the mammalian host
(45, 46). Activatedmacrophages provide a key defense response to
the invading pathogens and exert cytotoxic effects via NADPH
oxidase (NOX)-mediated production of superoxide and ROS that
result in enhanced oxidative modification of DNA, proteins, and
lipids (53, 54). Alternatively, superoxide may combine with nitric
oxide to produce peroxynitrite and peroxynitrous acid that can
directly kill T. cruzi (55). Indeed, COL and SYL (versus TCC)
exhibited an enhanced capacity to survive in and escape from
macrophages (Fig. 8), and these responses were associated with
detection of low levels of oxidative and nitrosative stress in COL-
infected and SYL-infected (versus TCC-infected) macrophages
(Fig. 7) . The in vitro (Fig. 7) and in vivo (Fig. 1) data presented in
this study do not clarify whether the antioxidant network en-
hanced the capacity of the SYL and COL isolates to efficiently
scavenge ROS and nitric oxide (NO) or inhibit the macrophage
activation of oxidative and nitrosative response. Yet, our finding
of increased resistance of COL and SYL trypomastigotes to exog-
enous H2O2 and peroxynitrite-mediated killing (Fig. 6) implies
that the parasite’s ability to scavenge ROS/NO, at least partially,
provides it a survival advantage in immune cells. Others have pro-
vided direct biochemical evidence showing that TXNPx acts as a
hub to neutralize free radicals through peroxynitrite reductase
activity (56). An enhanced association between the protein level
and activity of tryparedoxin peroxidases (TXNPx) and viru-
lence of other isolates of DTU TcI-TcIV has also been noted
(35, 56). Thus, we surmise that intraphagosomal survival from
ROS and ˙NO is the key to the parasite’s existence in the host
and that, irrespective of the phylogenetic lineage, T. cruzi iso-
lates capable of utilizing an antioxidant network to avoid oxidative
damage would likely ensure their survival, dissemination, and
persistence in the host. The increase in the expression of FeSODa
in SYL and COL is in line with our interpretation, since the dis-
mutation of superoxidewill lead to a decrease in the concentration
of oxidative species.
It is important to note that after escaping from macrophages,
FIG 7 Macrophage activation of oxidative/nitrosative response, but not inflammatory cytokine response, is deregulated by the antioxidant status of the TcI
strains of T. cruzi. RAW 264.7 macrophages were infected with COL, SYL, and TCC trypomastigotes for 24, 36, or 48 h. Normal (uninfected) cells, incubated for
similar time periods, were used as controls. (A) Cells were incubated for 24 h and then loadedwithH2DCFDA. The oxidation ofH2DCFDAby intracellular ROS,
resulting the in formation of fluorescent DCF, wasmonitored by fluorescencemicroscopy. (B andC) Supernatants were used tomeasure ROS (B) and nitrite (C)
levels by anAmplex red and aGriess reagent assay, respectively. (D andE)TNF- (D) and IL-6 (E) cytokines in supernatant samplesweremonitored by anELISA.
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T. cruzi faces oxidative stress in other tissues as well. For example,
we have shown enhanced mitochondrial production of ROS in
cardiomyocytes during T. cruzi infection (33). It is plausible that
T. cruzi utilizes antioxidant enzyme network to prevent mito-
chondrial ROS-mediated direct killing or ROS activation of the
apoptosis pathway for removal of the infected (or damaged) cells
(57), thereby ensuring its persistence in the host. A consequence of
prolonged survival of infected (damaged) cells is the signaling of
cell repair and proliferative responses, culminating in cardiac fi-
brosis (58). Further studies are required to demonstrate the novel
role of TXNPx/TXN in establishing a cardiac remodeling environ-
ment in Chagas disease; however, if such is the case, inhibiting the
parasite antioxidant activity will provide a novel strategy to man-
age the homeostatic clearance of damaged cells (and parasite) and
control the fibrotic processes that culminate in cardiomyopathy in
chronic Chagas disease.
In summary, we conclude that T. cruzi virulent isolates ensure
survival and persistence in the host via peroxiredoxin-dependent
decomposition of macrophage-derived free radicals. This is evi-
denced by our findings in the infective stage of the virulent para-
site isolates (COL and SYL), i.e., an upregulation of the protein
levels for cTXNPx, mTXNPx, and TXN I that readily detoxified
cytotoxic and diffusible reactive oxygen and nitrogen species gen-
erated in vitro or released by the macrophages. The absence of
differences in inflammatory cytokine levels (i.e., TNF- and IL-6)
inmacrophages infectedwith virulent or nonvirulent isolates ofT.
cruzi suggests that the peroxiredoxin-based antioxidant system
only helps the parasite to cope with the oxidative challenge with-
out interfering with the cytokine signaling. Further characteriza-
tion of the parasite’s antioxidant network in tissues from infected
experimental animals at different stages of infection and disease
development would support its role in the pathogenesis and par-
asite persistence and provide a strong basis for the development of
new chemotherapeutic options against T. cruzi.
T. cruzi isolates have been characterized as belonging to the TcI
to TcVI lineages. Efforts establishing an association between par-
asite lineage and pathogenicity have not been successful.We dem-
onstrate that parasite isolates of the same lineage exhibit a variable
virulence in mice. An unbiased proteomic approach, followed by
targeted studies, showed that the differential abundance of the
peroxiredoxin antioxidants and the flagellar proteins allowed in-
traphagosomal survival from oxidative/nitrosative stress and par-
asite dissemination and persistence. Thus, gene expression con-
ducive to enhanced antioxidant capacity andmotility, irrespective
of phylogenetic lineage, provided virulence to T. cruzi and should
be evaluated for identifying virulent isolates circulating in the
Americas.
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